Skip to content
healthcare.dev

Alyglo

NDC 61476-104, Human immunoglobulin G, liquid, from GC Biopharma Corp..

Product NDC
61476-104
Status
Listed
Labeler
GC Biopharma Corp.
Dosage form
LIQUID
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125743
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61476-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN IMMUNOGLOBULIN G100 mg/mL

Pharmacologic classes

Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]

Package NDCNDC-11Package
61476-104-05614760104051 VIAL, GLASS in 1 CARTON (61476-104-05) / 50 mL in 1 VIAL, GLASS (61476-104-01)
61476-104-10614760104101 VIAL, GLASS in 1 CARTON (61476-104-10) / 100 mL in 1 VIAL, GLASS (61476-104-02)
61476-104-20614760104201 VIAL, GLASS in 1 CARTON (61476-104-20) / 200 mL in 1 VIAL, GLASS (61476-104-03)

Linked data

RxNorm, label and prices

Use it

Look up 61476-104 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61476-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61476-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.